Literature DB >> 590334

Biphasic effects of amphetamine on striatal dopamine dynamics.

R Kuczenski.   

Abstract

S(+)-Amphetamine (AMPH) was administered to rats over the dose range 0.15-10.0 mg/kg (1.74(3)mumoles/kg) at various times before sacrifice. 15 min before sacrifice rats received an intraventricular injection of 3H-tyrosine, and the accumulation of striatal 3H-dopamine (DA) was assessed as an index of striatal DA formation and utilization. 3H-DA formation exhibited a biphasic dose response to AMPH. At 16 and 31 min after AMPH administration, 3H-DA accumulation increased linearly in response to AMPH to a maximal rate of 200% of control values at 1.0 mg/kg, then declined to less than 50% of control values at AMPH doses of 5 and 10 mg/kg. As a function of time, low doses of AMPH (to 2.0 mg/kg)) only increased 3H-DA accumulation, whereas high doses of AMPH (greater than 2.5 mg/kg) only decreased 3H-DA accumulation. All doses of AMPH increased endogenous levels of striatal DA. The data are discussed in terms of compensatory adaptive mechanisms of the nigrostriatal dopaminergic pathway.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590334     DOI: 10.1016/0014-2999(77)90340-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Role of dopaminergic neurotransmission in locomotor stimulation by dexamphetamine and ethanol.

Authors:  U H Strömbom; B Liedman
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

2.  Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm.

Authors:  L Kokkinidis; R M Zacharko
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.

Authors:  R Kuczenski; D S Segal
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

4.  Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.

Authors:  M T Bardo; S L Bowling; R C Pierce
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

Authors:  C W Callaway; M P Johnson; L H Gold; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.

Authors:  K Svensson; A M Johansson; T Magnusson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

7.  The effects of (+)-amphetamine, alpha-methyltyrosine, and alpha-methylphenylalanine on the concentrations of m-tyramine and alpha-methyl-m-tyramine in rat striatum.

Authors:  D F Dougan; A M Duffield; P H Duffield; D N Wade
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

8.  Effects of chronic amphetamine or reserpine on self-stimulation responding: animal model of depression?

Authors:  N J Leith; R J Barrett
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

9.  Norepinephrine uptake inhibitors as biochemically and behaviorally selective antagonists of the locomotor stimulation induced by indirectly acting sympathomimetic aminetic amines in mice.

Authors:  T D Tyler; R E Tessel
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.